CELL THERAPY

Home>CELL THERAPY>Holoderm

Rosmir®

[Prescription drug]

Description

Rosmir® is a cell therapy product consisting of autologous fibroblasts developed for correction of nasojugal grooves, or tear trough deformities in adults. 

 

The fibroblasts are derived from patients' skin biopsies, expanded through culture, delivered suspended in medium and applied by intra-dermal injection. 

It was approved by MFDS in December 2017.


Indication

Improvement of nasojugal grooves

Active Ingredient

Cultured Autologous Fibroblasts